中/EN: 中文繁體 English

Investor Relations
IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
Corporate

Press Releases

2018

Please select

AUG
29

The United Laboratories International Holdings Limited Announces 2018 Interim Results, Turnover Increased by 13.6% to RMB3,793 Million Adjusted Core Business Profit Recorded a Significant Increase of 487.1% to RMB399.2 Million

MAR
29

The United Laboratories International Holdings Limited, Recorded a Turnaround with Profit in 2017 Annual Results, Sales Revenue of Recombinant Human Insulin Injection Products Continued to Increase Insulin Glargine Promoted Sales Growth